Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PHG | ABT |
|---|---|---|
| Price | $23.78 | $97.53 |
| Change today | ▼ 2.68% | ▼ 1.32% |
| Market cap | $23.24B | $168.76B |
| Return, 3 months | -12.6% | +6.6% |
| Return, year to date | -8.7% | -20.7% |
| Return, 1 year | -10.6% | -25.2% |
| P/E (TTM) | 18.2 | 31.6 |
| P/B | 1.8 | 3.3 |
| P/E percentile vs own 5y | 72nd | 69th |
| Dividend yield | 4.17% | 2.50% |
| Revenue growth (YoY, latest qtr) | +0.5% | +13.0% |
| Net profit growth (YoY) | +60.8% | -47.8% |
| Gross margin | 45.9% | 56.6% |
| Operating margin | 9.9% | 15.8% |
| Net margin | 6.3% | 11.6% |
| Return on equity | 10.2% | 10.7% |
| Analyst target vs. price | – | +27.5% |
| Analyst buy share | 0% | 100% |
| RSI (14) | 36 | 30 |
| 30-day volatility | 17.0% | 20.3% |
| Max drawdown, 1 year | -22.8% | -38.6% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
